Stereotaxis (STXS) Shares Outstanding (2010 - 2026)
Stereotaxis' (STXS) quarterly Shares Outstanding (Entity) came in at $97.5 million in Q1 2026, up 13.38% year-on-year from $86.0 million in Q1 2025, and up 2.26% on a QoQ basis from $95.3 million in Q4 2025.
Stereotaxis (STXS) Shares Outstanding (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Shares Outstanding (Entity) data on file, last reported at $97.5 million in Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 13.38% year-over-year to $97.5 million in Q1 2026; TTM through Mar 2026 was $97.5 million, a 13.38% increase from a year earlier, with the FY2025 full-year figure at $95.3 million, up 11.73% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $97.5 million, up from $95.3 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for STXS reached as high as $97.5 million in Q1 2026 and fell as low as $74.6 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $82.8 million across 5 years, with a median of $82.1 million in 2024.
- Across the five-year window, Shares Outstanding (Entity) climbed 0.34% in 2022 and increased 13.38% in 2026, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $74.9 million in 2022, then increased by 8.11% to $80.9 million in 2023, then grew by 5.41% to $85.3 million in 2024, then rose by 11.73% to $95.3 million in 2025, then gained by 2.26% to $97.5 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $97.5 million in Q1 2026, $95.3 million in Q4 2025, and $91.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 487.20 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 280.64 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 819.08 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 145.34 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 174.20 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 71.43 Mn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | 98.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.89 Mn |
| Dec 31, 2025 | 90.96 Mn |
| Sep 30, 2025 | 92.01 Mn |
| Jun 30, 2025 | 87.95 Mn |
| Mar 31, 2025 | 87.77 Mn |
| Dec 31, 2024 | 85.18 Mn |
| Sep 30, 2024 | 85.82 Mn |
| Jun 30, 2024 | 84.57 Mn |
| Mar 31, 2024 | 83.48 Mn |
| Dec 31, 2023 | 80.70 Mn |
| Sep 30, 2023 | 82.47 Mn |
| Jun 30, 2023 | 81.05 Mn |
| Mar 31, 2023 | 76.50 Mn |
| Dec 31, 2022 | 76.06 Mn |
| Sep 30, 2022 | 76.10 Mn |
| Jun 30, 2022 | 75.95 Mn |
| Mar 31, 2022 | 75.88 Mn |
| Dec 31, 2021 | 75.56 Mn |
| Sep 30, 2021 | 75.70 Mn |
| Jun 30, 2021 | 75.55 Mn |